Method for treating neurodegeneration

Details Method for treating neurodegeneration Method for treating neurodegeneration

A - Human Necessities

61

K

A61K 31/4015 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2368352

N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide is used for the preparation of medicaments, particularly of pharmaceutical compositions containing it as an active ingredient, for the treatment of neurodegeneration, in particular in post-stroke human patients. The early administration of nefiracetam in said pharmaceutical compositions after a stroke allows an improvement of the Activities of Daily Living and the recovery, or at least in improvement in the recovery of, the post-stroke patients.

On utilise du N-(2,6-diméthylphenyl)-2-(2-oxo-1-pyrrolidinyl)acétamide pour la préparation de médicaments, et en particulier de compositions pharmaceutiques dont il constitue le principe actif, pour le traitement de la neurodégénérescence, notamment chez des patients ayant subi une attaque. L'administration rapide après l'attaque de la néfiracétame contenue dans lesdites compositions amène une amélioration des activités quotidiennes et la récupération, au moins partielle, des patients.

Affiliated with

Also associated with

Rating

Method for treating neurodegeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating neurodegeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating neurodegeneration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1788748